| Date | Title | | | 01/29/10 | NuVasive Announces Preliminary Unaudited Full Year 2009 Financial Results| --Anticipates Full Year 2009 Revenue of Approximately $370 Million --Announces Full Year 2010 Revenue Guidance of $480 Million to $500 MillionSAN DIEGO, Jan 29, 2010 /PRNewswire via COMTEX/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, today announced preliminary unaudited financial results for the full year ended December 31, 2009.
NuVasive anticipates full year 2009 revenue of approximatel... |
|  | | 01/05/10 | NuVasive to Present at the 28th Annual J.P. Morgan Healthcare Conference| SAN DIEGO, Jan 05, 2010 /PRNewswire-FirstCall via COMTEX/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Alex Lukianov, Chairman and Chief Executive Officer, and Michael J. Lambert, Executive Vice President and Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco, California, on Tuesday, Januar... |
| |
|
Receive E-mail Alerts | 
RSS Feeds
Print Page | 
IR Contacts | 
Financial Tear Sheet